Receive drug landscape reports to screen competitors within 2 working days.
We unburden you by compiling a landscape of:
a substance
e.g. apixaban
an ATC5 code
e.g. B01AF02
495* - 795**
EUR
* ≤ 5 authorized brand names
** > 10 authorized brand names
an indication
e.g. thromboembolism
a pharmacotherapeutic class
e.g. DOAC
an EMA group
e.g. antithrombotic agents
995* - 1.795**
EUR
* ≤ 5 authorized brand names
** > 50 authorized brand names
Receive personalized CTG/CRM notifications by mail
easily follow-up specific brands, substances or groups
minimum three months
⚠️ only available for Pharma.be and Medaxes members
Do you frequently perform CTG monitoring? Check out our Farmanaut services.
a brand name
e.g. Eliquis
a substance
e.g. apixaban
195
EUR per month
an ATC4 code
e.g. B01AF - Direct Factor Xa Inhibitors
295
EUR per month
an EMA group
e.g. antithrombotic agents
395
EUR per month
EMA authorized medicines only
Follow up on relevant changes over the last year in a specific therapeutic landscape
in a mail report.
Do you regularly follow-up therapeutic landscapes? Check out our DIY Farmanaut services.
a substance
e.g. apixaban
a brand name
e.g. Eliquis
an ATC5 code
e.g. B01AF02
EUR per month
daily / monthly / quarterly
an ATC4 code
e.g. B01AF - Direct Factor Xa Inhibitors
an EMA group*
e.g. antithrombotic agents
EUR per month
daily / monthly / quarterly
* EMA authorized medicines only
Send us your in-house price list and get an extensive comparison report of official elements
such as the CNK, CTI-extended, prescribability flag, ex-factory and public prices.
Do you want to continuously monitor prescribability? Check out our DIY Farmanaut services.
< 50 SKUs
650
EUR
50 - 100 SKUs
850
EUR
100 - 250 SKUs
1.250
EUR
> 250 SKUs
1.950
EUR
Post Launch Follow-up
Supply problems monitoring
Quickly respond to shifts in medicine availability. Closely monitor the most relevant opportunities crossing your portfolio.
Weekly receive reports of Farmastatus supply problems of competitors with a Digile impact analysis.
EUR per month (yearly contract)
Price erosion analysis
Price evolution since 2018 and analysis of the most probable reason of price erosion of reimbursed drugs by:
from
EUR per report
custom analyzes and reports
integrating internal and external data silos
structuring and encoding data sets
e.g. in international standards such as SNOMED CT
web services and applications
e.g. dynamic dashboards
easy DIY Market intelligence
dr. Apr. Michael Ceulemans
Postdoctoral researcher, KU Leuven – Coordinator of the BELpREG research project on the use and safety of medicines during pregnancy
Ebook on market intelligence
Do you want to learn how to make medicinal data work for you?
In the ebook "Challenges in pharmaceutical market intelligence" you will learn more about
offered to you by Digile - download now >>
Digile (pronounced /ˈdɪd͡ʒ.aɪl/) is a Belgian digital health tech company founded by pharmacist An Crepel and computer scientist Karel De Loof. Both are passionate about digital innovation in healthcare and have accumulated over 15 years of experience in the field of digital drug information.
Meet the founders:
An Crepel
An is a Master in Pharmaceutical Sciences and holds a PhD in Medical Sciences.
She is a freelance pharmacist and has worked for eight years in the field of pharmacotherapeutic information and healthcare databases.
She has management experience and obtained additional certification in healthcare data literacy.
Karel De Loof
Karel holds a PhD and Master in Computer Sciences and has over eight years of experience in research and teaching in computer science at Ghent University. After that, he worked seven years as a consultant in the pharmaceutical sector.
He obtained additional certification in entrepreneurship, digital leadership and digital product management.
